Cargando…
Emerging therapies for PBC
Primary biliary cholangitis is an uncommon cholestatic liver disease predominantly affecting middle-aged women. Left untreated, there is a high risk of progression to end-stage liver disease. Few treatment options exist. To date, ursodeoxycholic acid (UDCA) and obeticholic acid (OCA) are the only me...
Autores principales: | Chascsa, David Maxwell Hunter, Lindor, Keith Douglas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Singapore
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7026299/ https://www.ncbi.nlm.nih.gov/pubmed/31970467 http://dx.doi.org/10.1007/s00535-020-01664-0 |
Ejemplares similares
-
Changing Nomenclature for PBC: From ‘Cirrhosis' to ‘Cholangitis'
por: Beuers, Ulrich, et al.
Publicado: (2015) -
Measurement properties of the PBC-40 and PBC-27: a Dutch validation study
por: de Veer, Rozanne C, et al.
Publicado: (2021) -
Hox-PBC Partnership Demystified
por: Sedwick, Caitlin
Publicado: (2012) -
PBC technology subgroup report
por: Siemko, Andrzej, et al.
Publicado: (2018) -
Pretransplant Evaluation and Liver Transplantation Outcome in PBC Patients
por: Mijic, Maja, et al.
Publicado: (2022)